|
KLF13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.061600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.629800E-01 |
| Normal-vs-Stage2 |
6.921900E-03 |
| Normal-vs-Stage3 |
5.18649999947662E-07 |
| Normal-vs-Stage4 |
7.26729999955822E-07 |
| Stage1-vs-Stage2 |
8.123500E-03 |
| Stage1-vs-Stage3 |
7.6360000544895E-09 |
| Stage1-vs-Stage4 |
6.60000000207717E-08 |
| Stage2-vs-Stage3 |
2.399400E-01 |
| Stage2-vs-Stage4 |
2.008800E-01 |
| Stage3-vs-Stage4 |
8.011400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.116090E-03 |
| Normal-vs-AfricanAmerican |
4.804600E-01 |
| Normal-vs-Asian |
9.963400E-01 |
| Caucasian-vs-AfricanAmerican |
3.336000E-01 |
| Caucasian-vs-Asian |
3.690600E-01 |
| AfricanAmerican-vs-Asian |
7.841000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.032040E-02 |
| Normal-vs-Female |
3.422200E-03 |
| Male-vs-Female |
4.323200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.892000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.047800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.135170E-03 |
| Normal-vs-Age(81-100Yrs) |
5.234200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.837000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.013000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.651800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.313040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.633000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.807200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.610300E-02 |
| Normal-vs-Grade 2 |
7.556200E-01 |
| Normal-vs-Grade 3 |
1.63787999999387E-05 |
| Normal-vs-Grade 4 |
4.80429995786125E-09 |
| Grade 1-vs-Grade 2 |
1.039980E-01 |
| Grade 1-vs-Grade 3 |
1.794100E-04 |
| Grade 1-vs-Grade 4 |
5.71599999998895E-07 |
| Grade 2-vs-Grade 3 |
4.51040000004621E-06 |
| Grade 2-vs-Grade 4 |
2.43639997066225E-09 |
| Grade 3-vs-Grade 4 |
1.928180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.427000E-01 |
| Normal-vs-ccB subtype |
3.50239999999946E-05 |
| ccA subtype-vs-ccB subtype |
2.34299999999354E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.808130E-04 |
| Normal-vs-N1 |
4.395700E-04 |
| N0-vs-N1 |
2.116400E-01 |
|
|
